Section: Pet Parasites

Toxoplasmosis in Cats: Zoonotic Transmission and Prevention

Introduction

Toxoplasmosis is a globally distributed parasitic zoonosis caused by the obligate intracellular apicomplexan protozoan Toxoplasma gondii. Felids, particularly domestic cats (Felis catus), serve as the definitive host in which the parasite completes its sexual cycle and sheds environmentally resistant oocysts into the environment [1, 2]. The parasite infects virtually all warm-blooded vertebrates as intermediate hosts [3, 4]. Zoonotic transmission from cats to humans, especially to pregnant women and immunocompromised individuals, represents a significant public health concern [5, 6, 7]. This article provides a detailed examination of T. gondii biology in cats, clinical manifestations, diagnostic approaches, therapeutic management, and evidence-based strategies for preventing zoonotic transmission.

Life Cycle and Transmission Dynamics

Definitive Host Biology

Toxoplasma gondii exhibits a heteroxenous life cycle with sexual reproduction confined to the feline intestinal epithelium [8, 2]. Following ingestion of tissue cysts (bradyzoites) from infected intermediate hosts such as rodents, birds, or raw meat, bradyzoites excyst in the feline small intestine and invade enterocytes [2]. Through a series of asexual divisions (types A, B, C, D, and E), the parasite undergoes merogony (schizogony), producing merozoites that subsequently differentiate into gametocytes [8]. Microgametes fertilize macrogametes to form unsporulated oocysts, which are shed in feces [2]. The prepatent period ranges from three to ten days after ingestion of tissue cysts, whereas ingestion of oocysts results in a longer prepatent period (18 days or more) [9, 10]. Shedding typically lasts one to three weeks, during which millions of oocysts can be excreted [4].

Oocyst Biology and Environmental Contamination

Unsporulated oocysts are non-infectious upon excretion but undergo sporulation in the environment within one to five days under aerobic conditions with adequate temperature and humidity [10]. Sporulated oocysts are highly resilient, remaining infective for months to years in soil, water, and on fomites [11, 9, 12]. Environmental contamination is a key driver of transmission to intermediate hosts and humans [11, 9, 3]. Studies have demonstrated high seroprevalence in cats and other animals in urban informal settlements, indicating widespread environmental exposure [11, 4].

The following table summarizes the main transmission routes for T. gondii in cats and humans:

Host Route of Infection Source
Cat (definitive) Ingestion of tissue cysts Infected rodent, bird, raw meat
Cat (definitive) Ingestion of sporulated oocysts Contaminated soil, water, fomites
Human (intermediate) Ingestion of tissue cysts Undercooked meat (especially pork, lamb, goat)
Human (intermediate) Ingestion of sporulated oocysts Contaminated soil, water, unwashed produce; contact with cat feces
Human (intermediate) Vertical transmission Primary maternal infection during pregnancy
Human (intermediate) Transfusion / transplantation Infected blood products or organs

Intermediate Host Infection

Herbivorous and omnivorous intermediate hosts, including livestock (sheep, goats, pigs, cattle) and wildlife, acquire infection through ingestion of sporulated oocysts from contaminated pastures or feed [3, 13, 14, 15, 12]. In pregnant intermediate hosts, tachyzoites can cross the placenta and cause fetal infection, leading to abortion or congenital disease [16, 5, 13, 17]. Carnivorous and omnivorous hosts also acquire infection by consuming tissue cysts [18, 19]. The sylvatic cycle involves wild felids, rodents, and birds, while the domestic cycle revolves around pet cats and peridomestic rodents [19, 4].

Clinical Signs in Cats

Most immunocompetent cats remain asymptomatic after primary infection [10, 20]. Clinical disease, when it occurs, is most frequently observed in kittens, stressed adults, or immunocompromised cats (e.g., FIV-positive or FeLV-positive individuals) [21]. The clinical presentation reflects the tissue tropism of tachyzoites.

Ocular Toxoplasmosis

Ocular involvement occurs as a result of tachyzoite invasion of the retina and choroid, leading to chorioretinitis, uveitis, and retinal detachment [22]. Anterior uveitis may manifest as aqueous flare, miosis, and hypotony. Posterior segment lesions include focal necrotizing retinitis. Ocular toxoplasmosis can be unilateral or bilateral and may recur after resolution [22].

Neurological Toxoplasmosis

Neurological signs result from necrotizing encephalomyelitis [23]. Affected cats may present with ataxia, head tilt, circling, seizures, cranial nerve deficits, and altered mentation. Cerebral toxoplasmosis in immunocompromised individuals (including cats and humans) is a rare but severe complication [23].

Systemic Toxoplasmosis

Disseminated disease involves multiple organ systems including the lungs (interstitial pneumonia), liver (hepatic necrosis), pancreas (pancreatitis), and skeletal muscle (myositis) [21, 17]. Clinical signs include pyrexia, lethargy, anorexia, icterus, dyspnea, and abdominal pain. The disease can be rapidly fatal in neonates or immunocompromised hosts.

Diagnosis

Diagnosis of feline toxoplasmosis relies on a combination of serology, molecular detection, and histopathology [24, 25, 21, 26]. Ante-mortem diagnosis is challenging because oocyst shedding is intermittent and often ceases before clinical signs develop [9]. Therefore, serological testing remains the primary screening tool.

Serological Methods

Serum antibody detection using enzyme-linked immunosorbent assays (ELISA), indirect immunofluorescence assays (IFA), or modified agglutination tests (MAT) is widely used [1, 10, 20]. Immunoglobulin M (IgM) positivity suggests recent or active infection, while immunoglobulin G (IgG) indicates previous exposure or chronic infection [10]. Double-antigen sandwich colloidal gold immunochromatographic strips have been developed for rapid detection of antibodies across multiple host species, including cats [24]. SAG1-based immunochromatographic strips specifically detect anti-T. gondii IgG in swine and may be adapted for feline samples [25]. The MIC17A protein has shown promise as a marker for both entero-epithelial and chronic stage detection [21].

Molecular Detection

Polymerase chain reaction (PCR) assays targeting the B1 gene, 529 bp repeat element, or ribosomal DNA are highly sensitive and specific for detecting T. gondii DNA in tissues, blood, and feces [9, 26]. An antisense PCR assay designed for domestic cats has demonstrated improved sensitivity [26]. Molecular detection is particularly useful for confirming oocyst shedding in fecal samples and for diagnosis of aborted fetal tissues [16, 9, 13, 17]. PCR can differentiate T. gondii from closely related apicomplexans such as Neospora caninum [18, 19].

Histopathological Examination

Post-mortem diagnosis relies on identification of tachyzoites or tissue cysts in histological sections stained with hematoxylin and eosin or immunohistochemical stains [13, 17]. Characteristic findings include necrotizing lesions with collections of tachyzoites in brain, heart, skeletal muscle, and placenta.

Treatment

Treatment of clinical toxoplasmosis in cats aims to reduce tachyzoite multiplication and control inflammation. The standard therapeutic regimen combines an anti-folate antimicrobial with a sulfonamide or a macrolide antibiotic. Clindamycin (10-12 mg/kg orally every 12 hours for at least 4 weeks) is the first-line agent for systemic and ocular toxoplasmosis. Alternative regimens include pyrimethamine (0.25-0.5 mg/kg orally every 24 hours) combined with sulfadiazine (15 mg/kg orally every 12 hours), or azithromycin (5-10 mg/kg orally every 24 hours). Folinic acid supplementation is recommended when using pyrimethamine to mitigate bone marrow suppression. Corticosteroids (e.g., prednisolone 1-2 mg/kg orally every 12-24 hours) may be added for ocular or neurological cases to control inflammation. Treatment of oocyst shedding is not routinely indicated because shedding is short-lived and self-limiting; however, environmental decontamination and proper litter box management are critical.

Zoonotic Transmission

Routes of Zoonotic Transmission

Human infection occurs through three primary pathways. First, ingestion of sporulated oocysts from environments contaminated by feline feces (cat litter boxes, garden soil, sandboxes, contaminated produce or water) [11, 9, 10, 7]. Second, ingestion of tissue cysts in undercooked or raw meat from infected intermediate hosts (pork, lamb, goat, and to a lesser extent beef and chicken) [3, 15, 12]. Third, vertical transmission from a pregnant woman with primary infection acquired during gestation [5, 6, 7]. Other routes, such as blood transfusion, organ transplantation, and accidental laboratory inoculation, occur rarely [27, 23].

Risk Factors for Human Infection

Epidemiological studies have identified multiple risk factors: owning a cat with outdoor access or raw meat feeding practices [1, 10, 4]; living in areas with high environmental oocyst contamination (e.g., urban informal settlements) [11, 4]; occupational exposure (veterinary professionals, farmers, slaughterhouse workers) [28, 3]; consumption of raw or undercooked meat [3, 15]; and poor hand hygiene after handling soil or cat litter [6, 29]. In pregnant women, seronegativity before conception and lack of knowledge about toxoplasmosis are significant risk factors for primary infection [6, 29, 7]. A study in women with abortion or stillbirth history showed elevated seropositivity compared to controls, underscoring the importance of preventing primary infection during pregnancy [5].

Consequences of Zoonotic Infection

In immunocompetent individuals, primary infection usually is asymptomatic or causes a mild flu-like illness with lymphadenopathy. In immunocompromised hosts (transplant recipients, HIV/AIDS patients, those receiving immunosuppressive therapy), reactivation of latent infection can cause life-threatening encephalitis, myocarditis, or pneumonitis [23]. Primary infection during pregnancy carries the risk of vertical transmission. If the mother acquires infection shortly before or during gestation, tachyzoites can cross the placenta and cause fetal infection [5, 13, 7]. The severity of congenital toxoplasmosis depends on the gestational stage: early pregnancy infection often leads to severe disease (hydrocephalus, intracranial calcifications, chorioretinitis) or spontaneous abortion, while late pregnancy infection more commonly results in mild or subclinical disease at birth with possible later development of ocular lesions [5, 6, 7].

The following Mermaid diagram illustrates the major transmission pathways from cats to humans and the critical intervention points for prevention:

graph TD
    A[Cat ingests tissue cysts], > B[Sexual cycle in feline intestine]
    B, > C[Cat sheds unsporulated oocysts in feces]
    C, > D[Oocyst sporulation in environment]
    D, > E[Contaminated soil, water, produce, litter box]
    E, > F[Human ingestion of sporulated oocysts]
    F, > G[Primary human infection]
    G, > H{Immunocompetent?}
    H, >|Yes| I[Asymptomatic or mild illness]
    H, >|No| J[Severe toxoplasmosis]
    G, > K{Pregnant?}
    K, >|Yes| L[Vertical transmission to fetus]
    L, > M[Congenital toxoplasmosis]
    K, >|No| N[Latent infection]
    
    style L fill:#f96,stroke:#333,stroke-width:2px
    style F fill:#ffcc00,stroke:#333,stroke-width:2px

Prevention

Prevention of zoonotic toxoplasmosis requires a multifaceted approach targeting both feline and human behaviors.

Prevention of Feline Infection

Restricting outdoor access reduces the probability that a cat will prey on infected rodents and birds [1, 10, 7, 4]. Feeding only commercial cooked or processed cat food (canned, dry, or cooked meat) eliminates the ingestion of tissue cysts [7]. Litter boxes should be cleaned daily (before oocysts sporulate) using hot water (above 60 degrees Celsius) to inactivate oocysts. Pregnant women should avoid handling litter boxes whenever possible; if unavoidable, disposable gloves and careful hand hygiene are mandatory [6, 29, 7].

Prevention of Environmental Contamination

Cat feces should be disposed of in sealed bags and not placed in garden compost. Sandboxes should be covered when not in use to prevent defecation by stray cats [7, 4]. Vegetable gardens should be fenced to exclude cats. All produce that may have contacted contaminated soil should be thoroughly washed before consumption.

Prevention in Humans

Thorough hand washing after gardening, handling soil, or cleaning litter boxes is essential [6, 29, 7]. Meat should be cooked to an internal temperature of at least 66 degrees Celsius (well done) for pork, lamb, and goat; less stringent cooking may be sufficient for beef and poultry but remains advisable [3, 15]. Freezing meat to -20 degrees Celsius for several days inactivates tissue cysts. Pregnant women who are seronegative for T. gondii should receive detailed counseling on avoidance of all aforementioned risk factors, and some may be advised to have their cats tested for active infection [6, 7]. However, the majority of cats are either immune or no longer shedding, so testing is not routinely recommended unless oocyst shedding is suspected [10].

Vaccine Development

No licensed vaccine is available for cats or humans, but significant research progress has been made. Gene-edited live-attenuated vaccines using CRISPR-based knockout of virulence genes (e.g., knockout of ROP18 or GRA proteins) have shown efficacy in animal models by inducing protective immune responses without causing disease [30]. Advances in antigen discovery and mRNA vaccine platforms under the One Health framework offer promising avenues for future preventive strategies [31]. These developments may eventually reduce the zoonotic reservoir by immunizing cats and preventing oocyst shedding.

Conclusion

Toxoplasma gondii infection in cats remains a globally important zoonotic concern due to the parasite's unique sexual cycle in felids and the environmental persistence of oocysts. While most cats are asymptomatic, they serve as the primary source of oocysts that contaminate the environment and pose risks to humans, particularly pregnant women and immunocompromised individuals. Diagnosis relies on serology and molecular techniques, and treatment is indicated for clinical cases. Prevention hinges on limiting feline exposure to intermediate hosts, safe litter box hygiene, thorough hand washing, and proper food preparation. Emerging vaccine technologies may offer future tools for breaking the transmission cycle.


References

[1] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[2] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[3] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[4] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41401226/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[5] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[6] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[7] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[8] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[9] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[10] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[11] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[12] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/

[13] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/

[14] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[15] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/

[16] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[17] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/

[18] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[19] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[20] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41471183/

[21] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[22] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/

[23] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[24] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[25] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[26] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[27] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[28] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[29] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/

[30] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/

[31] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[32] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[33] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/

[34] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597614/

[35] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41481062/